Metsera

Biopharmaceutical company focusing on medicines for obesity and metabolic diseases

placeNew York City, New York, United States calendar_todayFounded 2022 language metsera.com

Registered entities

Social engagement

Social engagement: 13.2K social following, 6 posts in the last 12 months — top 10% of its industry.

Investor mix

17 investors on record; lead investors include Wellington, Venrock, Arch Venture Partners; 2 have since exited.

Investor typeCountShare
Venture capital953%
Private equity318%
Other / undisclosed529%

Recent activity

11 Sep 2025
Event
EASD2025
27 Aug 2025
Event
Cantor Global Healthcare Conference 2025
28 Jul 2025
Milestone
regulatory
Coming soon